vs
CALAVO GROWERS INC（CVGW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
CALAVO GROWERS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$124.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -26.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.2%）
卡拉沃种植者公司是一家国际化农产消费品企业，核心业务涉及牛油果及其他鲜果、新鲜预制食品的包装与分销，产品面向全球各地的餐饮门店、零售卖场以及个人客户供应，是生鲜果蔬领域颇具规模的供应商。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CVGW vs PBYI — 直观对比
营收规模更大
CVGW
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出54.4%
-26.6%
自由现金流更多
PBYI
多$13.2M
$1.2M
两年增速更快
PBYI
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.7M | $75.5M |
| 净利润 | $3.8M | — |
| 毛利率 | 9.3% | 69.3% |
| 营业利润率 | -1.4% | 22.7% |
| 净利率 | 3.1% | — |
| 营收同比 | -26.6% | 27.7% |
| 净利润同比 | 2846.0% | — |
| 每股收益（稀释后） | $0.22 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVGWPBYI
| Q4 25 | $124.7M | $75.5M | ||
| Q3 25 | $178.8M | $54.5M | ||
| Q2 25 | $190.5M | $52.4M | ||
| Q1 25 | $154.4M | $46.0M | ||
| Q4 24 | $170.0M | $59.1M | ||
| Q3 24 | $179.6M | $80.5M | ||
| Q2 24 | $184.4M | $47.1M | ||
| Q1 24 | $127.6M | $43.8M |
净利润CVGWPBYI
| Q4 25 | $3.8M | — | ||
| Q3 25 | $4.7M | $8.8M | ||
| Q2 25 | $6.8M | $5.9M | ||
| Q1 25 | $4.4M | $3.0M | ||
| Q4 24 | $-139.0K | — | ||
| Q3 24 | $-732.0K | $20.3M | ||
| Q2 24 | $6.1M | $-4.5M | ||
| Q1 24 | $-6.3M | $-4.8M |
毛利率CVGWPBYI
| Q4 25 | 9.3% | 69.3% | ||
| Q3 25 | 10.2% | 77.7% | ||
| Q2 25 | 9.5% | 76.5% | ||
| Q1 25 | 10.2% | 77.1% | ||
| Q4 24 | 9.7% | 76.4% | ||
| Q3 24 | 11.2% | 63.9% | ||
| Q2 24 | 11.1% | 77.4% | ||
| Q1 24 | 8.4% | 75.5% |
营业利润率CVGWPBYI
| Q4 25 | -1.4% | 22.7% | ||
| Q3 25 | 4.8% | 17.6% | ||
| Q2 25 | 4.0% | 12.7% | ||
| Q1 25 | 3.3% | 8.7% | ||
| Q4 24 | 1.8% | 22.6% | ||
| Q3 24 | 5.2% | 27.4% | ||
| Q2 24 | 4.0% | -4.6% | ||
| Q1 24 | -2.4% | -5.3% |
净利率CVGWPBYI
| Q4 25 | 3.1% | — | ||
| Q3 25 | 2.6% | 16.2% | ||
| Q2 25 | 3.6% | 11.2% | ||
| Q1 25 | 2.9% | 6.5% | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | -0.4% | 25.2% | ||
| Q2 24 | 3.3% | -9.6% | ||
| Q1 24 | -4.9% | -11.0% |
每股收益（稀释后）CVGWPBYI
| Q4 25 | $0.22 | $0.26 | ||
| Q3 25 | $0.26 | $0.17 | ||
| Q2 25 | $0.38 | $0.12 | ||
| Q1 25 | $0.25 | $0.06 | ||
| Q4 24 | $-0.01 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $0.34 | $-0.09 | ||
| Q1 24 | $-0.35 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $61.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $206.9M | $130.3M |
| 总资产 | $292.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CVGWPBYI
| Q4 25 | $61.2M | $97.5M | ||
| Q3 25 | $63.8M | $94.4M | ||
| Q2 25 | $60.4M | $96.0M | ||
| Q1 25 | $48.5M | $93.2M | ||
| Q4 24 | $57.0M | $101.0M | ||
| Q3 24 | $1.1M | $96.7M | ||
| Q2 24 | $4.3M | $96.8M | ||
| Q1 24 | $5.7M | $107.2M |
总债务CVGWPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CVGWPBYI
| Q4 25 | $206.9M | $130.3M | ||
| Q3 25 | $206.4M | $115.3M | ||
| Q2 25 | $206.6M | $104.7M | ||
| Q1 25 | $202.9M | $97.1M | ||
| Q4 24 | $200.3M | $92.1M | ||
| Q3 24 | $205.2M | $71.1M | ||
| Q2 24 | $207.3M | $48.5M | ||
| Q1 24 | $202.5M | $51.0M |
总资产CVGWPBYI
| Q4 25 | $292.2M | $216.3M | ||
| Q3 25 | $301.2M | $202.9M | ||
| Q2 25 | $321.5M | $194.9M | ||
| Q1 25 | $298.9M | $196.2M | ||
| Q4 24 | $301.1M | $213.3M | ||
| Q3 24 | $382.4M | $220.7M | ||
| Q2 24 | $411.4M | $205.0M | ||
| Q1 24 | $394.7M | $214.1M |
负债/权益比CVGWPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 1.0% | 19.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.60× | — |
| 过去12个月自由现金流最近4个季度 | $19.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CVGWPBYI
| Q4 25 | $2.3M | $14.4M | ||
| Q3 25 | $8.0M | $9.7M | ||
| Q2 25 | $15.7M | $14.1M | ||
| Q1 25 | $-4.4M | $3.6M | ||
| Q4 24 | $10.8M | $15.6M | ||
| Q3 24 | $11.4M | $11.0M | ||
| Q2 24 | $2.1M | $1.0M | ||
| Q1 24 | $58.0K | $11.2M |
自由现金流CVGWPBYI
| Q4 25 | $1.2M | $14.4M | ||
| Q3 25 | $7.3M | $9.7M | ||
| Q2 25 | $15.6M | $14.1M | ||
| Q1 25 | $-4.7M | $3.6M | ||
| Q4 24 | $10.5M | $15.6M | ||
| Q3 24 | $11.3M | $11.0M | ||
| Q2 24 | $745.0K | $1.0M | ||
| Q1 24 | $-972.0K | — |
自由现金流率CVGWPBYI
| Q4 25 | 1.0% | 19.1% | ||
| Q3 25 | 4.1% | 17.7% | ||
| Q2 25 | 8.2% | 26.8% | ||
| Q1 25 | -3.1% | 7.7% | ||
| Q4 24 | 6.2% | 26.4% | ||
| Q3 24 | 6.3% | 13.7% | ||
| Q2 24 | 0.4% | 2.1% | ||
| Q1 24 | -0.8% | — |
资本支出强度CVGWPBYI
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率CVGWPBYI
| Q4 25 | 0.60× | — | ||
| Q3 25 | 1.69× | 1.10× | ||
| Q2 25 | 2.29× | 2.41× | ||
| Q1 25 | -1.00× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVGW
| Fresh Products | $104.7M | 84% |
| Segment Prepared | $14.5M | 12% |
| Tomatoes | $4.6M | 4% |
PBYI
暂无分部数据
